NCT00486356 2024-01-03
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
Phase 1 Completed
University of Nebraska
Institut Bergonié
Roswell Park Cancer Institute
University of Southern California
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)